{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:13:20Z","timestamp":1788884000871,"version":"build-2803163510"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG056921"],"award-info":[{"award-number":["R21AG056921"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG058822"],"award-info":[{"award-number":["R01AG058822"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014041","name":"Alzheimer\u2019s Disease Neuroimaging Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007742","name":"BioClinica, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004896","name":"Eisai Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"F. Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014400","name":"Fujirebio US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013327","name":"Lundbeck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck & Co., Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,13]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Body mass index (BMI) is a risk factor for Alzheimer\u2019s disease (AD) although the relationship is complex. Obesity in midlife is associated with increased risk for AD, whereas evidence supports both higher and lower BMI increasing risk for AD in late life. This study examined the influence of individual differences in genetic risk for AD to further clarify the relationship between late-life BMI and conversion to AD. Participants included 52 individuals diagnosed as having mild cognitive impairment (MCI) at baseline who converted to AD within 24 months and 52 matched MCI participants from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) cohort. BMI was measured at baseline. Genetic risk for AD was assessed via genome-wide polygenic risk scores. Conditional logistic regression models were run to determine if BMI and polygenic risk predicted conversion to AD. Results showed an interaction between BMI and genetic risk, such that individuals with lower BMI and higher polygenic risk were more likely to convert to AD relative to individuals with higher BMI. These results remained significant after adjusting for cerebrospinal fluid biomarkers of AD. Exploratory sex-stratified analyses revealed this relationship only remained significant in males. These results show that higher genetic risk in the context of lower BMI predicts conversion to AD in the next 24 months, particularly among males. These findings suggest that genetic risk for AD in the context of lower BMI may serve as a prodromal risk factor for future conversion to AD.<\/jats:p>","DOI":"10.1093\/gerona\/glab117","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T10:03:01Z","timestamp":1618999381000},"page":"1415-1422","source":"Crossref","is-referenced-by-count":27,"title":["Body Mass Index and Polygenic Risk for Alzheimer\u2019s Disease Predict Conversion to Alzheimer\u2019s Disease"],"prefix":"10.1093","volume":"76","author":[{"given":"Jena N","family":"Moody","sequence":"first","affiliation":[{"name":"Department of Psychology, The Ohio State University, Columbus, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate E","family":"Valerio","sequence":"additional","affiliation":[{"name":"Department of Psychology, The Ohio State University, Columbus, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander N","family":"Hasselbach","sequence":"additional","affiliation":[{"name":"Department of Psychology, The Ohio State University, Columbus, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Prieto","sequence":"additional","affiliation":[{"name":"Department of Psychology, The Ohio State University, Columbus, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W","family":"Logue","sequence":"additional","affiliation":[{"name":"National Center for PTSD, VA Boston Healthcare System, Massachusetts, USA"},{"name":"Psychiatry and Biomedical Genetics, Boston University School of Medicine, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M","family":"Hayes","sequence":"additional","affiliation":[{"name":"Department of Psychology, The Ohio State University, Columbus, USA"},{"name":"Chronic Brain Injury Initiative, The Ohio State University, Columbus, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5157-0666","authenticated-orcid":false,"given":"Jasmeet P","family":"Hayes","sequence":"additional","affiliation":[{"name":"Department of Psychology, The Ohio State University, Columbus, USA"},{"name":"Chronic Brain Injury Initiative, The Ohio State University, Columbus, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"issue":"19","key":"2022042100011349800_CIT0001","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"2022042100011349800_CIT0002","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2022042100011349800_CIT0003","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"issue":"9","key":"2022042100011349800_CIT0004","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/archneurol.2009.106","article-title":"Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts","volume":"66","author":"Farias","year":"2009","journal-title":"Arch Neurol"},{"key":"2022042100011349800_CIT0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.dadm.2017.05.007","article-title":"Body mass index in midlife and dementia: systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies","volume":"8","author":"Albanese","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"issue":"6","key":"2022042100011349800_CIT0006","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(17)30084-4","article-title":"Neurological consequences of obesity","volume":"16","author":"O\u2019Brien","year":"2017","journal-title":"Lancet Neurol"},{"key":"2022042100011349800_CIT0007","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbi.2014.04.001","article-title":"Obesity and neuroinflammation: a pathway to cognitive impairment","volume":"42","author":"Miller","year":"2014","journal-title":"Brain Behav Immun"},{"issue":"2","key":"2022042100011349800_CIT0008","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/obr.12629","article-title":"Obesity as a risk factor for Alzheimer\u2019s disease: weighing the evidence","volume":"19","author":"Alford","year":"2018","journal-title":"Obes Rev"},{"key":"2022042100011349800_CIT0009","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/mp.2015.205","article-title":"Assessing the genetic overlap between BMI and cognitive function","volume":"21","author":"Marioni","year":"2016","journal-title":"Mol Psychiatry"},{"issue":"13","key":"2022042100011349800_CIT0010","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archinte.163.13.1524","article-title":"An 18-year follow-up of overweight and risk of Alzheimer disease","volume":"163","author":"Gustafson","year":"2003","journal-title":"Arch Intern Med"},{"issue":"10","key":"2022042100011349800_CIT0011","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s12603-017-0906-3","article-title":"Late-life body mass index, rapid weight loss, apolipoprotein E \u03b54 and the risk of cognitive decline and incident dementia","volume":"21","author":"Bell","year":"2017","journal-title":"J Nutr Health Aging"},{"issue":"3\u20134","key":"2022042100011349800_CIT0012","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000444216","article-title":"Body mass index predicts progression of mild cognitive impairment to dementia","volume":"41","author":"Cova","year":"2016","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2022042100011349800_CIT0013","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.exger.2017.10.013","article-title":"Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer\u2019s pathology in MCI and mild dementia","volume":"100","author":"Mathys","year":"2017","journal-title":"Exp Gerontol"},{"issue":"6","key":"2022042100011349800_CIT0014","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1212\/01.wnl.0000176061.33817.90","article-title":"Change in body mass index and risk of incident Alzheimer disease","volume":"65","author":"Buchman","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"2022042100011349800_CIT0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1749-6632.1990.tb16897.x","article-title":"Serotonin in Alzheimer-type dementia and other dementing illnesses","volume":"600","author":"Cross","year":"1990","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"2022042100011349800_CIT0016","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/WNL.46.6.1585","article-title":"Low body weight in Alzheimer\u2019s disease is associated with mesial temporal cortex atrophy","volume":"46","author":"Grundman","year":"1996","journal-title":"Neurology"},{"issue":"6","key":"2022042100011349800_CIT0017","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1192\/bjp.154.6.801","article-title":"Eating habits in dementia. A descriptive study","volume":"154","author":"Morris","year":"1989","journal-title":"Br J Psychiatry"},{"issue":"suppl. 1","key":"2022042100011349800_CIT0018","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3233\/JAD-180763","article-title":"Impacts of overweight and obesity in older age on the risk of dementia: a systematic literature review and a meta-analysis","volume":"70","author":"Danat","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"2022042100011349800_CIT0019","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"Gatz","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"2022042100011349800_CIT0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/WAD.0000000000000013","article-title":"Gene\u2013environment interaction of body mass index and apolipoprotein E \u03b54 allele on cognitive decline","volume":"28","author":"Rajan","year":"2014","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"2022042100011349800_CIT0021","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3233\/JAD-170064","article-title":"Relationship between body mass index, ApoE4 status, and PET-based amyloid and neurodegeneration markers in amyloid-positive subjects with normal cognition or mild cognitive impairment","volume":"65","author":"Blautzik","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"2022042100011349800_CIT0022","doi-asserted-by":"crossref","first-page":"200.e13","DOI":"10.1016\/j.neurobiolaging.2016.02.024","article-title":"Assessment of the genetic variance of late-onset Alzheimer\u2019s disease","volume":"41","author":"Ridge","year":"2016","journal-title":"Neurobiol Aging"},{"issue":"11","key":"2022042100011349800_CIT0023","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1093\/cercor\/bhr348","article-title":"The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects","volume":"22","author":"Sabuncu","year":"2012","journal-title":"Cereb Cortex"},{"issue":"3","key":"2022042100011349800_CIT0024","doi-asserted-by":"crossref","first-page":"e1002258","DOI":"10.1371\/journal.pmed.1002258","article-title":"Genetic assessment of age-associated Alzheimer disease risk: development and validation of a polygenic hazard score","volume":"14","author":"Desikan","year":"2017","journal-title":"PLoS Med"},{"key":"2022042100011349800_CIT0025","doi-asserted-by":"crossref","first-page":"102156","DOI":"10.1016\/j.nicl.2019.102156","article-title":"Body mass index is associated with smaller medial temporal lobe volume in those at risk for Alzheimer\u2019s disease","volume":"25","author":"Hayes","year":"2020","journal-title":"NeuroImage Clin"},{"key":"2022042100011349800_CIT0026","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fpsyt.2018.00142","article-title":"Body mass index in mild cognitive impairment according to age, sex, cognitive intervention, and hypertension and risk of progression to Alzheimer\u2019s disease","volume":"9","author":"Joo","year":"2018","journal-title":"Front Psychiatry"},{"issue":"3","key":"2022042100011349800_CIT0027","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat Genet"},{"issue":"7","key":"2022042100011349800_CIT0028","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jalz.2015.05.009","article-title":"Genetic studies of quantitative MCI and AD phenotypes in ADNI: progress, opportunities, and plans","volume":"11","author":"Saykin","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"5","key":"2022042100011349800_CIT0029","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jalz.2015.09.009","article-title":"Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of \u03b2-amyloid (1-42) in human cerebrospinal fluid","volume":"12","author":"Bittner","year":"2016","journal-title":"Alzheimers Dement"},{"key":"2022042100011349800_CIT0030","doi-asserted-by":"crossref","DOI":"10.1002\/9781118548387","volume-title":"Applied Logistic Regression","author":"Hosmer","year":"2013","edition":"2nd ed."},{"issue":"4","key":"2022042100011349800_CIT0031","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/00031305.1999.10474494","article-title":"The bagplot: a bivariate boxplot","volume":"53","author":"Rousseeuw","year":"1999","journal-title":"Am Stat"},{"issue":"1","key":"2022042100011349800_CIT0032","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1038\/s41467-020-18534-1","article-title":"Risk prediction of late-onset Alzheimer\u2019s disease implies an oligogenic architecture","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"2022042100011349800_CIT0033","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3233\/JAD-170286","article-title":"The relationship of brain amyloid load and APOE status to regional cortical thinning and cognition in the ADNI cohort","volume":"59","author":"Li","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"2022042100011349800_CIT0034","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.neuroimage.2010.02.068","article-title":"Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer\u2019s disease","volume":"51","author":"Stein","year":"2010","journal-title":"Neuroimage"},{"issue":"7","key":"2022042100011349800_CIT0035","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2018.04.017","article-title":"A longitudinal imaging genetics study of neuroanatomical asymmetry in Alzheimer\u2019s disease","volume":"84","author":"Wachinger","year":"2018","journal-title":"Biol Psychiatry"},{"issue":"5","key":"2022042100011349800_CIT0036","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000506","article-title":"Genetic risk for Alzheimer disease predicts hippocampal volume through the human lifespan","volume":"6","author":"Walhovd","year":"2020","journal-title":"Neurol Genet"},{"issue":"1","key":"2022042100011349800_CIT0037","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13073-016-0355-3","article-title":"Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer\u2019s disease","volume":"8","author":"Wang","year":"2016","journal-title":"Genome Med"},{"issue":"3","key":"2022042100011349800_CIT0038","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"issue":"1","key":"2022042100011349800_CIT0039","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.b.32499","article-title":"Genomic variants, genes, and pathways of Alzheimer\u2019s disease: an overview","volume":"174","author":"Naj","year":"2017","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"2022042100011349800_CIT0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0925-4439(00)00040-5","article-title":"Oxidative stress in Alzheimer\u2019s disease","volume":"1502","author":"Smith","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"2022042100011349800_CIT0041","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jalz.2017.09.016","article-title":"Body mass index and risk of dementia: analysis of individual-level data from 1.3 million individuals","volume":"14","author":"Kivim\u00e4ki","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"4","key":"2022042100011349800_CIT0042","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.maturitas.2015.08.006","article-title":"Prevalence and risk factors of sarcopenia among adults living in nursing homes","volume":"82","author":"Senior","year":"2015","journal-title":"Maturitas"},{"issue":"4","key":"2022042100011349800_CIT0043","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/ijms11041509","article-title":"Oxidative stress, molecular inflammation and sarcopenia","volume":"11","author":"Meng","year":"2010","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2022042100011349800_CIT0044","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"2022042100011349800_CIT0045","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S2666-7568(20)30007-6","article-title":"Associations between physical frailty and dementia incidence: a prospective study from UK Biobank","volume":"1","author":"Petermann-Rocha","year":"2020","journal-title":"Lancet Healthy Longev"},{"issue":"2","key":"2022042100011349800_CIT0046","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(18)30371-5","article-title":"Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer\u2019s disease: a cross-sectional analysis of data from the Rush Memory and Aging Project","volume":"18","author":"Wallace","year":"2019","journal-title":"Lancet Neurol"},{"issue":"9B","key":"2022042100011349800_CIT0047","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1111\/j.1582-4934.2009.00733.x","article-title":"Inflammation and frailty measures in older people","volume":"13","author":"Hubbard","year":"2009","journal-title":"J Cell Mol Med"},{"key":"2022042100011349800_CIT0048","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.maturitas.2017.01.006","article-title":"Oxidative stress and frailty: a systematic review and synthesis of the best evidence","volume":"99","author":"Soysal","year":"2017","journal-title":"Maturitas"},{"key":"2022042100011349800_CIT0049","doi-asserted-by":"crossref","first-page":"108115","DOI":"10.1016\/j.neuropharm.2020.108115","article-title":"Insulin and leptin as potential cognitive enhancers in metabolic disorders and Alzheimer\u2019s disease","volume":"171","author":"Mejido","year":"2020","journal-title":"Neuropharmacology"},{"issue":"2","key":"2022042100011349800_CIT0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/YCO.0000000000000401","article-title":"Sex differences in Alzheimer\u2019s disease","volume":"31","author":"Laws","year":"2018","journal-title":"Curr Opin Psychiatry"},{"issue":"11","key":"2022042100011349800_CIT0051","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/gerona\/gls068","article-title":"The role of androgens and estrogens on healthy aging and longevity","volume":"67","author":"Horstman","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2022042100011349800_CIT0052","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neubiorev.2015.08.021","article-title":"Obesity and sex interact in the regulation of Alzheimer\u2019s disease","volume":"67","author":"Moser","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"issue":"11","key":"2022042100011349800_CIT0053","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.exger.2004.06.019","article-title":"Low free testosterone is an independent risk factor for Alzheimer\u2019s disease","volume":"39","author":"Hogervorst","year":"2004","journal-title":"Exp Gerontol"},{"issue":"1","key":"2022042100011349800_CIT0054","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/mp.2012.147","article-title":"Associations between gonadotropins, testosterone and \u03b2 amyloid in men at risk of Alzheimer\u2019s disease","volume":"19","author":"Verdile","year":"2014","journal-title":"Mol Psychiatry"},{"issue":"11","key":"2022042100011349800_CIT0055","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41582-018-0070-3","article-title":"Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease","volume":"14","author":"Kivipelto","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"2022042100011349800_CIT0056","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(15)00033-9","article-title":"BMI and risk of dementia in two million people over two decades: a retrospective cohort study","volume":"3","author":"Qizilbash","year":"2015","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Journals of Gerontology: Series A"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/biomedgerontology\/advance-article-pdf\/doi\/10.1093\/gerona\/glab117\/37955432\/glab117.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/76\/8\/1415\/38938605\/glab117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/76\/8\/1415\/38938605\/glab117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T22:54:00Z","timestamp":1724885640000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article\/76\/8\/1415\/6242465"}},"subtitle":[],"editor":[{"given":"David","family":"Le Couteur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":56,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,4,21]]},"published-print":{"date-parts":[[2021,7,13]]}},"URL":"https:\/\/doi.org\/10.1093\/gerona\/glab117","relation":{},"ISSN":["1079-5006","1758-535X"],"issn-type":[{"value":"1079-5006","type":"print"},{"value":"1758-535X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2021,4,21]]}}}